Mitsunobu Matsubara

4.9k total citations · 1 hit paper
105 papers, 4.0k citations indexed

About

Mitsunobu Matsubara is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mitsunobu Matsubara has authored 105 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mitsunobu Matsubara's work include Blood Pressure and Hypertension Studies (21 papers), Ion Transport and Channel Regulation (17 papers) and Hormonal Regulation and Hypertension (16 papers). Mitsunobu Matsubara is often cited by papers focused on Blood Pressure and Hypertension Studies (21 papers), Ion Transport and Channel Regulation (17 papers) and Hormonal Regulation and Hypertension (16 papers). Mitsunobu Matsubara collaborates with scholars based in Japan, United States and United Kingdom. Mitsunobu Matsubara's co-authors include Yutaka Imai, Mari Michimata, Atsushi Hozawa, Ichiro Tsuji, Masahiro Kikuya, Hiroshi Satoh, Tsutomu Araki, Takayoshi Ohkubo, Shigeru Hisamichi and Junichiro Hashimoto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Mitsunobu Matsubara

105 papers receiving 3.9k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure

2002 825 citations Takayoshi Ohkubo, Atsushi Hozawa et al. Journal of Hypertension profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitsunobu Matsubara Japan	34	2.1k	708	556	548	405	105	4.0k
Srinivas Sriramula United States	26	1.6k 0.8×	943 1.3×	634 1.1×	514 0.9×	435 1.1×	59	3.6k
Peter Dominiak Germany	32	2.2k 1.0×	1.1k 1.6×	707 1.3×	426 0.8×	722 1.8×	132	4.8k
Yusuke Ohya Japan	32	1.4k 0.7×	846 1.2×	440 0.8×	636 1.2×	574 1.4×	178	3.5k
Masashi Akaike Japan	35	1.3k 0.6×	1.3k 1.9×	604 1.1×	820 1.5×	623 1.5×	116	4.4k
Takuya Kishi Japan	39	2.4k 1.2×	945 1.3×	477 0.9×	704 1.3×	1.0k 2.6×	190	4.6k
A. Carayon France	26	1.3k 0.6×	702 1.0×	393 0.7×	542 1.0×	846 2.1×	98	3.7k
David C. Kem United States	31	1.3k 0.6×	951 1.3×	1.2k 2.2×	996 1.8×	385 1.0×	95	3.5k
Dulce Elena Casarini Brazil	39	2.0k 0.9×	1.1k 1.6×	1.0k 1.8×	327 0.6×	758 1.9×	209	4.5k
Mari Michimata Japan	20	1.5k 0.7×	301 0.4×	349 0.6×	374 0.7×	202 0.5×	41	2.3k
Ichiro Wakabayashi Japan	29	831 0.4×	778 1.1×	983 1.8×	405 0.7×	743 1.8×	271	3.8k

Countries citing papers authored by Mitsunobu Matsubara

Since Specialization

Citations

This map shows the geographic impact of Mitsunobu Matsubara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsunobu Matsubara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsunobu Matsubara more than expected).

Fields of papers citing papers by Mitsunobu Matsubara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsunobu Matsubara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsunobu Matsubara. The network helps show where Mitsunobu Matsubara may publish in the future.

Co-authorship network of co-authors of Mitsunobu Matsubara

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsunobu Matsubara. A scholar is included among the top collaborators of Mitsunobu Matsubara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsunobu Matsubara. Mitsunobu Matsubara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hatano, Ryo, et al.. (2018). Internalization of NKCC2 is impaired in thick ascending limb of Henle in moesin knockout mice. Pflügers Archiv - European Journal of Physiology. 470(7). 1055–1068. 7 indexed citations

Kazama, Itsuro, N. ABE, Yasuhiro Endo, et al.. (2016). Clarithromycin Dose-Dependently Stabilizes Rat Peritoneal Mast Cells. Chemotherapy. 61(6). 295–303. 13 indexed citations

Kazama, Itsuro, et al.. (2014). Benidipine Suppresses in situ Proliferation of Leukocytes and Slows the Progression of Renal Fibrosis in Rat Kidneys with Advanced Chronic Renal Failure. Nephron Experimental Nephrology. 128(1-2). 67–79. 16 indexed citations

Kazama, Itsuro, Yoshio Maruyama, & Mitsunobu Matsubara. (2012). Benidipine persistently inhibits delayed rectifier K⁺-channel currents in murine thymocytes. Immunopharmacology and Immunotoxicology. 35(1). 28–33. 22 indexed citations

Toyama, Hiroaki, et al.. (2009). Potential for erythropoietin synthesis in kidney of uraemic rat alters depending on severity of renal failure. Nephrology. 14(8). 735–742. 8 indexed citations

Suzuki, M., et al.. (2007). Clinical and histological responses of renal amyloidosis to high-dose melphalan supported by autologous stem cell transplantation. Nephrology Dialysis Transplantation. 23(2). 747–750. 2 indexed citations

Matsubara, Mitsunobu, et al.. (2005). Benidipine, a dihydropyridine-calcium channel blocker, inhibits lysophosphatidylcholine-induced endothelial injury via stimulation of nitric oxide release. Pharmacological Research. 53(1). 35–43. 25 indexed citations

Asayama, Kei, Takayoshi Ohkubo, Takuya Nishimura, et al.. (2004). Progress Report on the HOMED‐BP Study: Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure Study. Clinical and Experimental Hypertension. 26(2). 119–127. 7 indexed citations

Kikuya, Masahiro, Ken Sugimoto, Tomohiro Katsuya, et al.. (2003). A/C1166 Gene Polymorphism of the Angiotensin II Type 1 Receptor (AT1) and Ambulatory Blood Pressure: The Ohasama Study.. Hypertension Research. 26(2). 141–145. 43 indexed citations

10.

Hashimoto, Junichiro, Takashi Ugajin, Junko Yamaguchi, et al.. (2003). Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension. Journal of Hypertension. 21(4). 805–811. 36 indexed citations

11.

Michimata, Mari, Itsuro Kazama, Tsutomu Araki, et al.. (2003). Urinary Concentration Defect and Limited Expression of Sodium Cotransporter, rBSC1, in a Rat Model of Chronic Renal Failure. Nephron Physiology. 93(2). p34–p41. 19 indexed citations

12.

Kurosaki, R., Yukiko Muramatsu, Hiroshi Watanabe, et al.. (2003). Role of Dopamine Transporter Against MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) Neurotoxicity in Mice. Metabolic Brain Disease. 18(2). 139–146. 26 indexed citations

13.

Fukuda, Masayuki, Takayoshi Ohkubo, Tomohiro Katsuya, et al.. (2002). Association of a Mast Cell Chymase Gene Variant with HDL Cholesterol, but not with Blood Pressure in the Ohasama Study. Hypertension Research. 25(2). 179–184. 15 indexed citations

14.

Hashimoto, Junichiro, Takayoshi Ohkubo, Ichiro Tsuji, et al.. (2002). INSUFFICIENT DURATION OF ACTION OF ANTIHYPERTENSIVE DRUGS MEDIATES HIGH BLOOD PRESSURE IN THE MORNINGIN HYPERTENSIVE POPULATION:THE OHASAMA STUDY. Clinical and Experimental Hypertension. 24(4). 261–275. 56 indexed citations

15.

Matsubara, Mitsunobu, Michiko Suzuki, Tohru Fujiwara, et al.. (2002). Angiotensin-converting enzyme I/D polymorphism and hypertension: The Ohasama study. Journal of Hypertension. 20(6). 1121–1126. 49 indexed citations

16.

Kurosaki, R., et al.. (2002). Effects of Ca2+ antagonists on motor activity and the dopaminergic system in aged mice. Neurobiology of Aging. 24(2). 315–319. 15 indexed citations

17.

Hozawa, Atsushi, Takayoshi Ohkubo, Ichiro Tsuji, et al.. (2001). Predictive values of automated blood pressure measurement: what can we learn from the Japanese population – the Ohasama study. Blood Pressure Monitoring. 6(6). 335–339. 35 indexed citations

18.

Takata, Satoru, Mitsunobu Matsubara, Philip G. Allen, et al.. (1994). Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium.. Journal of Clinical Investigation. 93(2). 499–508. 68 indexed citations

19.

Takahashi, Hideo, Makoto Tominaga, Hideo Sasaki, et al.. (1990). Three Cases of Diabetic Nephropathy Successfully Treated with Camostat Mesilate. 33(12). 973–978. 1 indexed citations

20.

Matsubara, Mitsunobu, et al.. (1990). Effect of camostat mesilate for the treatment of advanced diabetic nephropathy.. PubMed. 116(2). 206–10. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact